Critical roles of STAT3 in β-adrenergic functions in the heart

Circulation

Volumn 133, Issue 1, 2016, Pages 48-61

  Zhang, Wenjun ^a,b   Qu, Xiuxia ^a   Chen, Biyi ^c   Snyder, Marylynn ^d   Wang, Meijing ^e   Li, Baiyan ^b,f   Tang, Yue ^a   Chen, Hanying ^b   Zhu, Wuqiang ^b   Zhan, Li ^b   Yin, Ni ^b,g   Li, Deqiang ^b   Xie, Li ^b,g   Liu, Ying ^b   Zhang, J Jillian ^d   Fu, Xin Yuan ^e   Rubart, Michael ^b   Song, Long Sheng ^c   Huang, Xin Yun ^d   Shou, Weinian ^a,b  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e INDIANA UNIVERSITY   (United States)

^f HARBIN MEDICAL UNIVERSITY   (China)

^g CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

heart failure; receptors, adrenergic; receptors, G protein coupled; STAT3 transcription factor

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CALCIUM CHANNEL T TYPE; CHORIONIC GONADOTROPIN ALPHA SUBUNIT; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOXYCYCLINE; PHOSPHOLAMBAN; PROTEIN TYROSINE KINASE; STAT3 PROTEIN; TROPONIN I; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; STAT3 PROTEIN, MOUSE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CALCIUM CURRENT; CELL DEATH; CONTROLLED STUDY; HEART CONTRACTION; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE RELAXATION; HEART VENTRICLE HYPERTROPHY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; YOUNG ADULT; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE CELL; CELL LINE; DRUG EFFECTS; HEART; KNOCKOUT MOUSE; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY;

ADRENERGIC BETA-AGONISTS; ANIMALS; CELL LINE; HEART; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCYTES, CARDIAC; ORGAN CULTURE TECHNIQUES; RECEPTORS, ADRENERGIC, BETA; STAT3 TRANSCRIPTION FACTOR;

EID: 84953733202     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.017472     Document Type: Article

References (47)

1. Lefkowitz RJ, Rockman HA, Koch WJ., Catecholamines, cardiac beta-Adrenergic receptors, and heart failure. Circulation 2000 101 1634 1637
2. Rockman HA, Koch WJ, Lefkowitz RJ., Seven-Transmembrane-spanning receptors and heart function. Nature 2002 415 206 212. doi: 10.1038/415206a.
3. Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, Rasmussen R, Zera P, Menlove R, Shah P, Jamieson S., Beta 1-and beta 2-Adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res 1986 59 297 309
4. Koch WJ, Lefkowitz RJ, Rockman HA., Functional consequences of altering myocardial adrenergic receptor signaling. Annu Rev Physiol 2000 62 237 260. doi: 10.1146/annurev.physiol.62.1.237.
5. Lohse MJ, Engelhardt S, Eschenhagen T., What is the role of beta-Adrenergic signaling in heart failure? Circ Res 2003 93 896 906. doi: 10.1161/01.RES.0000102042.83024.CA.
6. Zhu WZ, Wang SQ, Chakir K, Yang D, Zhang T, Brown JH, Devic E, Kobilka BK, Cheng H, Xiao RP., Linkage of beta1-Adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. J Clin Invest 2003 111 617 625. doi: 10.1172/JCI16326.
7. Singh K, Communal C, Sawyer DB, Colucci WS., Adrenergic regulation of myocardial apoptosis. Cardiovasc Res 2000 45 713 719
8. Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, Della Rocca GJ, Lin F, Kawakatsu H, Owada K, Luttrell DK, Caron MG, Lefkowitz RJ., Beta-Arrestin-Dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 1999 283 655 661
9. Lavoie C, Mercier JF, Salahpour A, Umapathy D, Breit A, Villeneuve LR, Zhu WZ, Xiao RP, Lakatta EG, Bouvier M, Hébert TE., Beta 1/beta 2-Adrenergic receptor heterodimerization regulates beta 2-Adrenergic receptor internalization and ERK signaling efficacy. J Biol Chem 2002 277 35402 35410. doi: 10.1074/jbc.M204163200.
10. Ma YC, Huang J, Ali S, Lowry W, Huang XY., Src tyrosine kinase is a novel direct effector of G proteins. Cell 2000 102 635 646
11. Noma T, Lemaire A, Naga Prasad SV, Barki-Harrington L, Tilley DG, Chen J, Le Corvoisier P, Violin JD, Wei H, Lefkowitz RJ, Rockman HA., Beta-Arrestin-mediated beta1-Adrenergic receptor transactivation of the EGFR confers cardioprotection. J Clin Invest 2007 117 2445 2458. doi: 10.1172/JCI31901.
12. Kim IM, Tilley DG, Chen J, Salazar NC, Whalen EJ, Violin JD, Rockman HA., Beta-blockers alprenolol and carvedilol stimulate beta-Arrestin-mediated EGFR transactivation. Proc Natl Acad Sci U S A 2008 105 14555 14560. doi: 10.1073/pnas.0804745105.
13. Bromberg JF, Darnell JE Jr., Potential roles of Stat1 and Stat3 in cellular transformation. Cold Spring Harb Symp Quant Biol 1999 64 425 428
14. Levy DE, Lee CK., What does Stat3 do? J Clin Invest 2002 109 1143 1148. doi: 10.1172/JCI15650.
15. Stark GR, Darnell JE Jr., The JAK-STAT pathway at twenty. Immunity 2012 36 503 514. doi: 10.1016/j.immuni.2012.03.013.
16. Fischer P, Hilfiker-Kleiner D., Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis. Basic Res Cardiol 2007 102 279 297. doi: 10.1007/s00395-007-0658-z.
17. Ng DC, Court NW, dos Remedios CG, Bogoyevitch MA., Activation of signal transducer and activator of transcription (STAT) pathways in failing human hearts. Cardiovasc Res 2003 57 333 346
18. Tsoutsman T, Kelly M, Ng DC, Tan JE, Tu E, Lam L, Bogoyevitch MA, Seidman CE, Seidman JG, Semsarian C., Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy. Circulation 2008 117 1820 1831. doi: 10.1161/CIRCULATIONAHA.107.755777.
19. Jacoby JJ, Kalinowski A, Liu MG, Zhang SS, Gao Q, Chai GX, Ji L, Iwamoto Y, Li E, Schneider M, Russell KS, Fu XY., Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age. Proc Natl Acad Sci U S A 2003 100 12929 12934. doi: 10.1073/pnas.2134694100.
20. Hilfiker-Kleiner D, Hilfiker A, Fuchs M, Kaminski K, Schaefer A, Schieffer B, Hillmer A, Schmiedl A, Ding Z, Podewski E, Podewski E, Poli V, Schneider MD, Schulz R, Park JK, Wollert KC, Drexler H., Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ Res 2004 95 187 195. doi: 10.1161/01.RES.0000134921.50377.61.
21. Wu B, Zhou B, Wang Y, Cheng HL, Hang CT, Pu WT, Chang CP, Zhou B., Inducible cardiomyocyte-specific gene disruption directed by the rat Tnnt2 promoter in the mouse. Genesis 2010 48 63 72. doi: 10.1002/dvg.20573.
22. Hang CT, Yang J, Han P, Cheng HL, Shang C, Ashley E, Zhou B, Chang CP., Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature 2010 466 62 67. doi: 10.1038/nature09130.
23. Kim KK, Soonpaa MH, Daud AI, Koh GY, Kim JS, Field LJ., Tumor suppressor gene expression during normal and pathologic myocardial growth. J Biol Chem 1994 269 22607 22613
24. Chen H, Yong W, Ren S, Shen W, He Y, Cox KA, Zhu W, Li W, Soonpaa M, Payne RM, Franco D, Field LJ, Rosen V, Wang Y, Shou W., Overexpression of bone morphogenetic protein 10 in myocardium disrupts cardiac postnatal hypertrophic growth. J Biol Chem 2006 281 27481 27491. doi: 10.1074/jbc.M604818200.
25. Huang C, Gu H, Zhang W, Manukyan MC, Shou W, Wang M., SDF-1/CXCR4 mediates acute protection of cardiac function through myocardial STAT3 signaling following global ischemia/reperfusion injury. Am J Physiol Heart Circ Physiol 2011 301 H1496 H1505. doi: 10.1152/ajpheart.00365.2011.
26. Wang M, Zhang W, Crisostomo P, Markel T, Meldrum KK, Fu XY, Meldrum DR., Endothelial STAT3 plays a critical role in generalized myocardial proinflammatory and proapoptotic signaling. Am J Physiol Heart Circ Physiol 2007 293 H2101 H2108. doi: 10.1152/ajpheart.00125.2007.
27. Bastepe M, Gunes Y, Perez-Villamil B, Hunzelman J, Weinstein LS, Jüppner H., Receptor-mediated adenylyl cyclase activation through XLalpha(s), the extra-large variant of the stimulatory G protein alpha-subunit. Mol Endocrinol 2002 16 1912 1919. doi: 10.1210/me.2002-0054.
28. Sun Y, Huang J, Xiang Y, Bastepe M, Jüppner H, Kobilka BK, Zhang JJ, Huang XY., Dosage-Dependent switch from G protein-coupled to G protein-independent signaling by a GPCR. EMBO J 2007 26 53 64. doi: 10.1038/sj.emboj.7601502.
29. Sulakhe PV, Vo XT., Regulation of phospholamban and troponin-I phosphorylation in the intact rat cardiomyocytes by adrenergic and cholinergic stimuli: roles of cyclic nucleotides, calcium, protein kinases and phosphatases and depolarization. Mol Cell Biochem 1995 149-150 103 126
30. Chen X, Xu H, Yuan P, Fang F, Huss M, Vega VB, Wong E, Orlov YL, Zhang W, Jiang J, Loh YH, Yeo HC, Yeo ZX, Narang V, Govindarajan KR, Leong B, Shahab A, Ruan Y, Bourque G, Sung WK, Clarke ND, Wei CL, Ng HH., Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008 133 1106 1117. doi: 10.1016/j.cell.2008.04.043.
31. Kidder BL, Yang J, Palmer S., Stat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells. PLoS One 2008 3 e3932. doi: 10.1371/journal.pone.0003932.
32. Martínez ML, Heredia MP, Delgado C., Expression of T-Type Ca(2+) channels in ventricular cells from hypertrophied rat hearts. J Mol Cell Cardiol 1999 31 1617 1625. doi: 10.1006/jmcc.1999.0998.
33. Kinoshita H, Kuwahara K, Takano M, Arai Y, Kuwabara Y, Yasuno S, Nakagawa Y, Nakanishi M, Harada M, Fujiwara M, Murakami M, Ueshima K, Nakao K., T-Type Ca2+ channel blockade prevents sudden death in mice with heart failure. Circulation 2009 120 743 752. doi: 10.1161/CIRCULATIONAHA.109.857011.
34. Montgomery RL, Davis CA, Potthoff MJ, Haberland M, Fielitz J, Qi X, Hill JA, Richardson JA, Olson EN., Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev 2007 21 1790 1802. doi: 10.1101/gad.1563807.
35. Chiang CS, Huang CH, Chieng H, Chang YT, Chang D, Chen JJ, Chen YC, Chen YH, Shin HS, Campbell KP, Chen CC., The Ca(v)3.2 T-Type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice. Circ Res 2009 104 522 530. doi: 10.1161/CIRCRESAHA.108.184051.
36. Nuss HB, Houser SR., T-Type Ca2+ current is expressed in hypertrophied adult feline left ventricular myocytes. Circ Res 1993 73 777 782
37. Yin F, Li P, Zheng M, Chen L, Xu Q, Chen K, Wang YY, Zhang YY, Han C., Interleukin-6 family of cytokines mediates isoproterenol-induced delayed STAT3 activation in mouse heart. J Biol Chem 2003 278 21070 21075. doi: 10.1074/jbc.M211028200.
38. Szabo-Fresnais N, Lefebvre F, Germain A, Fischmeister R, Pomérance M., A new regulation of IL-6 production in adult cardiomyocytes by beta-Adrenergic and IL-1 beta receptors and induction of cellular hypertrophy by IL-6 trans-signalling. Cell Signal 2010 22 1143 1152. doi: 10.1016/j.cellsig.2010.03.009.
39. Cambi GE, Lucchese G, Djeokeng MM, Modesti A, Fiaschi T, Faggian G, Sani G, Modesti PA., Impaired JAK2-induced activation of STAT3 in failing human myocytes. Mol Biosyst 2012 8 2351 2359. doi: 10.1039/c2mb25120e.
40. Kuwahara K, Saito Y, Takano M, Arai Y, Yasuno S, Nakagawa Y, Takahashi N, Adachi Y, Takemura G, Horie M, Miyamoto Y, Morisaki T, Kuratomi S, Noma A, Fujiwara H, Yoshimasa Y, Kinoshita H, Kawakami R, Kishimoto I, Nakanishi M, Usami S, Saito Y, Harada M, Nakao K., NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function. EMBO J 2003 22 6310 6321. doi: 10.1093/emboj/cdg601.
41. Tanaka H, Shigenobu K., Efonidipine hydrochloride: a dual blocker of L-and T-Type ca(2+) channels. Cardiovasc Drug Rev 2002 20 81 92
42. Jenkins BJ, Grail D, Nheu T, Najdovska M, Wang B, Waring P, Inglese M, McLoughlin RM, Jones SA, Topley N, Baumann H, Judd LM, Giraud AS, Boussioutas A, Zhu HJ, Ernst M., Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling. Nat Med 2005 11 845 852. doi: 10.1038/nm1282.
43. Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, Forster O, Quint A, Landmesser U, Doerries C, Luchtefeld M, Poli V, Schneider MD, Balligand JL, Desjardins F, Ansari A, Struman I, Nguyen NQ, Zschemisch NH, Klein G, Heusch G, Schulz R, Hilfiker A, Drexler H., A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007 128 589 600. doi: 10.1016/j.cell.2006.12.036.
44. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB., Decreased catecholamine sensitivity and beta-Adrenergic-receptor density in failing human hearts. N Engl J Med 1982 307 205 211. doi: 10.1056/NEJM198207223070401.
45. Brodde OE, Vogelsang M, Broede A, Michel-Reher M, Beisenbusch-Schäfer E, Hakim K, Zerkowski HR., Diminished responsiveness of Gs-coupled receptors in severely failing human hearts: no difference in dilated versus ischemic cardiomyopathy. J Cardiovasc Pharmacol 1998 31 585 594
46. Podewski EK, Hilfiker-Kleiner D, Hilfiker A, Morawietz H, Lichtenberg A, Wollert KC, Drexler H., Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy. Circulation 2003 107 798 802
47. Tsoutsman T, Bagnall RD, Semsarian C., Impact of multiple gene mutations in determining the severity of cardiomyopathy and heart failure. Clin Exp Pharmacol Physiol 2008 35 1349 1357. doi: 10.1111/j.1440-1681.2008.05037.x.